Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc > Kalytera never delivered. Claritas won't be any better.

<< Previous

Bullboard Posts

Next >>

Post by losingmyshirton Jan 05, 2022 11:36am

170 Views

Post# 34285368

Kalytera never delivered. Claritas won't be any better.

Are you that dense that you do not see what is happening. There was plenty of hype, and I mean plenty of hype, about GVHD that Kalytera was working on.

We all know that none of you made any money with that.

Claritas will continue to promise. but cannot ever deliver.

A pretty sure bet that Claritas will disappear before Covid does.

Hey Bob, why not ask Elizabeth Holmes to join your team.

<< Previous

Bullboard Posts

Next >>

Gold vs. bitcoin, where should you invest?